Life Sciences - Europe-wide
What the team is known for
Bristows has expertise in pan-European IP matters, with a solid reputation in cross-border matters of both a transactional and contentious nature. The law firm advises leading life science clients on patent litigation, with notable strength in revocation and enforcement proceedings. It also represents clients in market authorisation files, assisting with development and commercialisation of new products. Bristows also continues to be active for leading research teams in landmark cases relating to COVID-19 vaccines and variants, and testing.
Strengths
"Bristows is a very good firm, particularly in coordinating multi-jurisdictional litigation. They have a good network of colleagues across Europe."
"They are really great, client-centric, and very knowledgeable about the industry. The Bristows team comes up with pragmatic solutions, and adds a personal touch to advice. They have a solid team across the board. I do not see them as just there to make a profit. They are efficient and true partners."
Work highlights
Bristows acted for Teva on a challenge to invalidate Grűnenthal's patents covering testosterone undecanoate, used to treat hypogonadism, low testosterone levels in men and for hormone therapy for transgender men.
Notable practitioners
Liz Cohen and Richard Dickinson, based in London, head the firm's life sciences practice and are key points of contact.
